Several studies have been reported that heart rate is known to be associated with prognosis in chronic diseases and acute diseases. For example, a decrease in heart rate following myocardial infarction may lead to a higher mortality rate. It is also known to predict heart failure, diabetic neuropathy, and even depression. The combined pituitary function test artificially induces hypoglycemia to observe the secretion of pituitary hormone. The degree of change in heart rate during hypoglycemia can predict the adequacy of the test, and heart rate can be changed according to the characteristic of the tumor. Also, the prognosis can be predicted based on this. In our study, we used a licensed device approved by KFDA (Korea Food and Drug Administration) to measure heart rate variability in patients with pituitary adenoma.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
50
Case management consists of confirmation of hospital visit date, checking the adverse effect
Seoul St. Mary's hospital
Seoul, South Korea
RECRUITINGChanges in Heart rate variability according to the types of pituitary adenoma
Time frame: 5 month of initial recruit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.